Postoperative pathology revealed the recurrent tumor was consistent with breast origin, lobular in nature, ER > 66%, progesterone receptor (PR) 34% to 66%, HER2 IHC of +2, with a negative silver in situ hybridization (SISH) result. The gene discussed is ESR1; the disease is neoplasm.